Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Butt

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
International Journal of Epidemiology|July 15, 2024
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adultsLing Yang, Christiana Kartsonaki, Julia Simon, et al.
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2020
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort ConsortiumJulia Butt, William J Blot, Kala Visvanathan, et al.
Plos One|September 3, 2025
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposuresChristopher S Semancik, Romain Fantin, Julia Butt, et al.
European Journal of Neurology|June 9, 2021
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.
International Journal of Epidemiology|March 13, 2023
Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysisPang Yao, Christiana Kartsonaki, Julia Butt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Racial Differences in <i>Helicobacter pylori</i> CagA Sero-prevalence in a Consortium of Adult Cohorts in the United StatesMatthew G Varga, Julia Butt, William J Blot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2025
Antibody Responses to 11 Fusobacterium Proteins and Colorectal Cancer-Specific and Overall Survival in the EPIC CohortDominique S Michaud, Elizabeth A Platz, Wendy S Garrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 19, 2021
Prediagnostic Antibody Responses to <i>Fusobacterium nucleatum</i> Proteins Are Not Associated with Risk of Colorectal Cancer in a Large U.S. ConsortiumChun-Han Lo, William J Blot, Lauren R Teras, et al.
Microorganisms|November 4, 2020
Association of Combined Sero-Positivity to <i>Helicobacter pylori</i> and <i>Streptococcus gallolyticus</i> with Risk of Colorectal CancerMeira Epplein, Loïc Le Marchand, Timothy L Cover, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
International Journal of Epidemiology|July 15, 2024
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adultsLing Yang, Christiana Kartsonaki, Julia Simon, et al.
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2020
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort ConsortiumJulia Butt, William J Blot, Kala Visvanathan, et al.
Plos One|September 3, 2025
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposuresChristopher S Semancik, Romain Fantin, Julia Butt, et al.
European Journal of Neurology|June 9, 2021
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.
International Journal of Epidemiology|March 13, 2023
Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysisPang Yao, Christiana Kartsonaki, Julia Butt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Racial Differences in <i>Helicobacter pylori</i> CagA Sero-prevalence in a Consortium of Adult Cohorts in the United StatesMatthew G Varga, Julia Butt, William J Blot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 6, 2025
Antibody Responses to 11 Fusobacterium Proteins and Colorectal Cancer-Specific and Overall Survival in the EPIC CohortDominique S Michaud, Elizabeth A Platz, Wendy S Garrett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 19, 2021
Prediagnostic Antibody Responses to <i>Fusobacterium nucleatum</i> Proteins Are Not Associated with Risk of Colorectal Cancer in a Large U.S. ConsortiumChun-Han Lo, William J Blot, Lauren R Teras, et al.
Microorganisms|November 4, 2020
Association of Combined Sero-Positivity to <i>Helicobacter pylori</i> and <i>Streptococcus gallolyticus</i> with Risk of Colorectal CancerMeira Epplein, Loïc Le Marchand, Timothy L Cover, et al.
Pageof 13